Efficacy of bone melon extract injection combined with calcitriol in patients after surgery for osteoporotic vertebral compression fractures
10.3760/cma.j.cn341190-20240506-00512
- VernacularTitle:骨瓜提取物注射液联合骨化三醇用于骨质疏松性椎体压缩性骨折术后患者疗效观察
- Author:
Yong WU
1
;
Fang YU
;
Long CAI
Author Information
1. 咸阳市第一人民医院药剂科，咸阳 712000
- Publication Type:Journal Article
- Keywords:
Spine;
Fractures, compression;
Osteoporotic fractures;
Drug therapy, combination;
Calcitriol;
Interleukin-1;
Interleukin-6;
Bone density
- From:
Chinese Journal of Primary Medicine and Pharmacy
2025;32(10):1503-1508
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the efficacy of bone melon extract injection combined with calcitriol in patients after surgery for osteoporotic vertebral compression fractures.Methods:The clinical data of 108 patients with osteoporotic vertebral compression fractures who underwent percutaneous kyphoplasty at The First People's Hospital of Xianyang from January 2021 to January 2024 were retrospectively analyzed. The patients were divided into a control group ( n = 54, treatment with calcitriol) and a treatment group ( n = 54, treatment with bone melon extract injection and calcitriol). Both groups were treated for 3 months. Serum bone metabolism indexes, inflammatory factors, bone density, vertebral anterior edge height and Cobb angle were compared between the two groups before and after treatment. Additionally, adverse reactions, such as gastrointestinal symptoms, hypercalcemia, and allergic reactions were recorded. Results:After treatment, the levels of β-collagen degradation products in the treatment group were significantly lower than those in the control group [(0.75 ± 0.08) μg/L vs. (0.94 ± 0.10) μg/L; t = 10.90, P<0.001]. The serum levels of type I collagen amino-terminal peptide in the treatment group were significantly higher than those in the control group [(34.31 ± 3.56) μg/L vs. (29.64 ± 3.05) μg/L; t = -7.64, P<0.001]. The serum levels of interleukin-1 and interleukin-6 in the treatment group were (70.51 ± 7.13) ng/L and (60.74 ± 6.12) μg/L, respectively, which were significantly lower than those in the control group [(89.64 ± 8.66) ng/L, (71.65 ± 7.32) μg/L; t = 12.53, 8.40, both P<0.001]. The bone mineral densities of the femoral neck and L 1-L 4 in the treatment group were (0.77 ± 0.08) g/cm2 and (0.71 ± 0.07) g/cm2, respectively, both of which were significantly higher than those in the control group [(0.68 ± 0.07) g/cm2, (0.63 ± 0.06) g/cm2; t = -6.22, -6.38, both P<0.001]. Additionally, the anterior vertebral height in the treatment group was significantly greater than that in the control group [(29.03 ± 2.97) mm vs. (25.05 ± 2.61) mm; t = -7.40, P<0.001]. The Cobb angle in the treatment group was significantly lower than that in the control group [(21.39 ± 2.18)° vs. (27.63 ± 2.82)°; t = 12.87, P<0.001]. There was no statistically significant difference in the overall incidence of adverse reactions, such as gastrointestinal symptoms and hypercalcemia, between the two groups ( P>0.05). Conclusions:The treatment regimen using bone melon extract injection combined with calcitriol after surgery for osteoporotic vertebral compression fractures has shown considerable effects. It can reduce postoperative inflammatory responses, improve bone metabolism indicators, restore bone density and vertebral curvature in patients, and demonstrates high safety.
